Tej Pavoor is an operating partner at Flagship Pioneering and works closely with John Mendlein and other partners to increase value creation in selected NewCos and GrowthCos as well as drive operational and strategic initiatives.
Tej joins Flagship following six years at Moderna. In his most recent role as Senior Vice President, Investigational Medicines, Tej was responsible for program strategy and management of 21 programs across multiple therapeutic areas including vaccines. Prior to this role, Tej was head of Strategic Operations and led the project management of Moderna’s IPO process. He was also responsible for building Moderna’s preclinical production capability. Prior to Moderna, Tej was at McKinsey & Company where he was a leader in the Biopharmaceutical and Corporate Finance Practices. Tej began his career at Merck & Company in preclinical development of biologics.
Tej holds a Bachelor of Chemical Engineering degree from the University Institute of Chemical Technology in Mumbai and a Ph.D. in Chemical Engineering from the University of Wisconsin-Madison.